Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Lowered to $43 at Deutsche Bank
-
-
-
-
-
-
-
Teva's (TEVA) Deal for Allergan Generics Seen as Positive at Deutsche Bank, PT Raised to $82
-
-
-
-
-
-
-
Teva Pharma (TEVA) Price Target Raised to $68 at Deutsche Bank; Large & Small Deals Remain Priority, Notes Analyst
-
-
-
-
-
-
-
Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)
-
-
-
-
-
-
-
StreetInsider.com Pre-Open Movers 6/12: (CTB) (CYTK) (HMA) Higher; (CLSN) (FSLR) (IEP) Lower (more...)
-
-
-
-
-
-
-
Deutsche Bank Maintains a 'Buy' on Medicis (MRX) Post Meeting with Management at Company HQ
-
-
-
-
-
-
-
Notable Analyst Rating Changes 7/11: SPWR, APC, NDAQ Upgraded; ELN, TEVA, WB Downgraded
-
47,835 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All